Sector revisions Bristol-Myers Squibb Company

Equities

Market Closed - Nyse Other stock markets 04:00:02 2026-02-09 pm EST			Pre-market 07:38:28 pm
60.77 ^USD	-1.97%		60.53	-0.39%

Feb. 09	AstraZeneca's Evinova Enters Clinical Development AI Partnership Deal	MT
Feb. 06	Wells Fargo Adjusts Bristol-Myers Squibb PT to $60 From $55, Maintains Equal Weight Rating	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	BRISTOL-MYERS SQUIBB COMPANY							23
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							24
	ABBVIE INC.							27
	ROCHE HOLDING AG							20
	MERCK & CO., INC.							26
	ASTRAZENECA PLC							21
	NOVARTIS AG							21
	NOVO NORDISK A/S							22
	AMGEN INC.							27
	GILEAD SCIENCES, INC.							26
	PFIZER INC.							24
	VERTEX PHARMACEUTICALS INCORPORATED							25
	GSK PLC							20
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	BAYER AG							20
	Average							22
	Weighted average by Cap.							24